These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22129094)

  • 1. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
    Koinuma J; Akiyama H; Fujita M; Hosokawa M; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Cancer Sci; 2012 Mar; 103(3):577-86. PubMed ID: 22129094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.
    Chan D; Tsoi MY; Liu CD; Chan SH; Law SY; Chan KW; Chan YP; Gopalan V; Lam AK; Tang JC
    World J Gastroenterol; 2013 May; 19(18):2772-80. PubMed ID: 23687414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From cancer genomics to thoracic oncology: discovery of new biomarkers and therapeutic targets for lung and esophageal carcinoma.
    Daigo Y; Nakamura Y
    Gen Thorac Cardiovasc Surg; 2008 Feb; 56(2):43-53. PubMed ID: 18297458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.
    Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
    Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
    Wang Q; Ma C; Kemmner W
    BMC Cancer; 2013 Mar; 13():137. PubMed ID: 23514407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
    Yamabuki T; Takano A; Hayama S; Ishikawa N; Kato T; Miyamoto M; Ito T; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Kondo S; Nakamura Y; Daigo Y
    Cancer Res; 2007 Mar; 67(6):2517-25. PubMed ID: 17363569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
    Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
    Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
    Gong M; Xu Y; Dong W; Guo G; Ni W; Wang Y; Wang Y; An R
    Acta Histochem; 2013 Oct; 115(8):810-5. PubMed ID: 23664661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of differentially expressed miRNAs in esophageal cancer.
    Hu Y; Correa AM; Hoque A; Guan B; Ye F; Huang J; Swisher SG; Wu TT; Ajani JA; Xu XC
    Int J Cancer; 2011 Jan; 128(1):132-43. PubMed ID: 20309880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma.
    Liang YN; Liu Y; Meng Q; Li X; Wang F; Yao G; Wang L; Fu S; Tong D
    Med Oncol; 2015 Feb; 32(2):459. PubMed ID: 25588924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
    Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
    Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.
    He W; Wang Z; Wang Q; Fan Q; Shou C; Wang J; Giercksky KE; Nesland JM; Suo Z
    BMC Cancer; 2009 Dec; 9():426. PubMed ID: 19995427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.